Activin A and activin receptors in the human thyroid: A link to the female predominance of goiter?

Hormone and Metabolic Research

Volumn 32, Issue 10, 2000, Pages 390-400

  Schulte, K M ^a   Jonas, C ^a   Krebs, R ^a   Roher, H D ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Activin A; Alk; Cancer; Goiter; Inhibin A; Receptor; Thyroid

Indexed keywords

ACTIVIN A; ACTIVIN RECEPTOR; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY TEST; FEMALE; GOITER; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SEX DIFFERENCE; THYROID FOLLICLE CELL;

EID: 0033765364     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978660     Document Type: Article

References (57)

1. Prevalence of simple sporadic goiter in relation to other non-neoplastic thyroid pathologies in an internal medicine department
2. Comparative screening for thyroid disorders in old age in areas of iodine deficiency, long-term iodine prophylaxis and abundant iodine intake
3. The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham Survey
4. Epidemiology of thyroid diseases in iodine sufficiency
5. In vitro models of thyroid cancer
6. Molecular basis of epithelial tumorigenesis: The thyroid model
7. Molecular genetics of thyroid diseases
8. Growth factors in thyroid cells
9. The thyroid nodule - Molecular, genetic and cytogenetic aspects
10. Thyroid hormone modulates insulin-like growth factor-I(IGF-I) and IGF-binding protein-3, without mediation by growth hormone, in patients with autoimmune thyroid disease
11. Insulin-like growth factor-binding protein-3 (IGFBP-3) but not insulin-like growth factor-1 (IGF-I) remains elevated in euthyroid TSH-suppressed Graves' disease
12. Transforming growth factor beta regulates thyroid growth. Role in the pathogenesis of nontoxic goiter
13. Tumour-suppressor genes: Evolving definitions in the genomic age (news)
14. Tumor suppressor activity of the TGF-beta pathway in human cancers
15. Decreased type-II/type-I TGF-β receptor ratio in cells derived from human atherosclerotic lesions
16. Human malignant thyroid tumors displayed reduced levels of transforming growth factor beta receptor type II messenger RNA and protein
17. Expression of transforming growth factor-beta1 and transforming growth factor-beta type-II receptor mRNA in papillary thyroid carcinoma
18. Rare loss of heterozygozity of the multiple tumor suppressor genes MTS 1 and MTS 2 in differentiated human thyroid cancer
19. Inhibins, activins and follistatins: A review of complex regulators of the reproductive system
20. Influence of age and sex on serum concentrations of total dimeric activin A
21. Activins and ativin receptors in cell growth
22. Hormonally regulated components of the adrenocortical cell environment and the control of adrenal cortex homeostasis
23. Activin inhibits basal and androgen-stimulated proliferation and induces apoptosis in the human prostatic cancer cell line LNCaP
24. Involvement of p21 (WAF1/Cip1), CDK4 and Rb in activin A mediated signaling leading to hepatoma cell growth inhibition
25. Human recombinant activin-A inhibits proliferation of human fetal adrenal cells in vitro
26. Inhibitory effects of activin on the growth and morphologenesis of primary and transformed mammary epithelial cells
27. Effects of activin A on proliferation and differentiation of human lung fibroblasts
28. Effects of activin A on deoxyribonucleic acid synthesis, iodine metabolism, and cyclic adenosine monophosphate accumulation in porcine thyroid cells
29. Expression of transforming growth factor-beta-I, activin A, and their receptors in thyroid follicle cells: Negative regulation of thyrocyte growth and function
30. Immunohistochemical localization of alpha- and betaA-subunits of inhibin/activin in human normal endocrine cells and related tumors of the digestive system
31. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin
32. Betaglycan binds inhibin and can mediate functional antagonism of activin signaling
33. Activin receptor-like kinases: A novel subclass of cell-surface receptors with predicted serine/threonine kinase activity
34. A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor beta, or bone morphogenic factor
35. Chromosomal localization of three human genes encoding members of the TGF-beta superfamily of type I serine/threonine kinase receptors
36. Genomic structure and cloned cDNAs predict that four variants in the kinase domain of serine/threonine kinase receptors arise by alternative splicing and poly(A) addition
37. A short loop on the ALK-2 and ALK-4 activin receptors regulates signaling specificity but cannot account for all their effects on early Xenopus development
38. Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-β receptors in human pituitary adenomas
39. Molecular cloning and binding properties of the human type II activin receptor
40. Expression of type II activin receptor genes during differentiation of human K562 cells and cDNA cloning of the human type IIB activin receptor
41. Genomic organization and mapping of the human activin receptor type IIB (hActR-IIB) gene
42. Left-right axis malformations associated with mutations in ACVR2B, the gene for human activin receptor type IIB
43. Recombinant expression and characterization of human activin A
44. Immunochemical quantification of bromodeoxyuridine: Application to cell-cycle kinetics
45. A single step method of RNA isolation by acid guadinium thiocyanate-phenol-chloroform extraction
46. Cloning of TGFβ type 1 receptor that forms a heterodimeric complex with the TGFβ type II receptor
47. Bromodeoxyuridine: A diagnostic tool in biology and medicine, Part 1: Historical perspectives, histochemical methods and cell kinetics
48. Evaluation of a tretrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing
49. Apoptosis and growth factors in parathyroid adenomas
50. Fas-mediated apoptosis is inhibited by TSH and iodine in moderate concentrations in primary human thyrocytes in vitro
51. Activin and inhibin in the human adrenal gland. Regulation and differential effects in fetal and adult cells
52. General inhibition by transforming growth factor beta 1 of thyrotropin and cAMP responses in human thyroid cells in primary culture
53. Interaction between p53 and TGF beta 1 in control of epithelial cell proliferation
54. The ALK-2 and ALK-4 activin receptors transduce distinct mesoderm - Inducing signals during early Xenopus development but do not co-operate to establish thresholds
55. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2
56. Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids
57. Mutational analysis of activin/transforming growth factor-beta type 1 and type II receptor kinases in human pituitary tumors